スイス生殖医療法の改正 : 着床前診断の容認  [in Japanese] The Amendment of the Reproductive Medicine Act in Switzerland : Removal of the Ban on PGD  [in Japanese]

Access this Article

Search this Article

Author(s)

Abstract

Preimplantation genetic diagnosis (PGD) is a technique used for genetic testing of in-vitro-fertilized embryos to determine whether they are normal or not. This technique is spreading gradually to various countries. However, it is often criticized for its concept of "choice of life." In Switzerland, the Reproductive Medicine Act, which came into force on January 1, 2001, clearly prohibited PGD. The situation began changing in 2005, when the Swiss Parliament passed a motion to remove the ban on PGD. Finally, on December 12, 2014, the parliament approved amendments to the Reproductive Medicine Act and Article 119 of the Federal Constitution, regarding reproductive medicine and gene technology involving human beings. According to the revised Reproductive Medicine Act, PGD is permissible under appropriate conditions. In this article, I explain the process of the revision and examine the permissible conditions to carry out PGD.

Journal

  • 福井工業高等専門学校研究紀要. 自然科学・工学

    福井工業高等専門学校研究紀要. 自然科学・工学 (49), 211-226, 2016-03

    福井工業高等専門学校

Codes

  • NII Article ID (NAID)
    120005775285
  • NII NACSIS-CAT ID (NCID)
    AN0021492X
  • Text Lang
    JPN
  • Article Type
    departmental bulletin paper
  • Journal Type
    大学紀要
  • ISSN
    0386-3352
  • NDL Article ID
    027260096
  • NDL Call No.
    Z14-361
  • Data Source
    NDL  IR 
Page Top